Table 1.
All prescribers | Psychiatrists | Non-psychiatrist prescribers | |
---|---|---|---|
Oral naltrexone | 26.8 | 29.0 | 25.5 |
Long-acting naltrexone | 17.8 | 14.0 | 20.0 |
Disulfiram | 6.1 | 6.6 | 5.9 |
Acamprosate | 7.6 | 7.0 | 8.0 |
Topiramate | 4.2 | 5.2 | 3.7 |
Baclofen | 1.5 | 0.9 | 1.9 |
Other b | 14.6 | 14.6 | 14.2 |
None of the above | 6.8 | 6.2 | 7.2 |
Percentage of patients with AUD who were prescribed the listed medications. Only responses from prescribers were included in this analysis. Twenty-six percent of respondents did not complete this question. There was no statistically significant difference between psychiatrists and non-psychiatrists in the prescription rates for these medications.
More than half of “other” responses included gabapentin.
None of the differences shown in the table are statistically significant (i.e., p’s > 0.05).